Clinical trial Recruiting at 1 site Interventional Ages 40 and up

High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia

Official title: Gas Exchange, Clinical Outcomes, and Tolerability of High-Flow Nasal Cannula Versus Non-Invasive Ventilation in COPD Patients With Mild-to-Moderate Hypercapnic Respiratory Failure

Run by Mansoura University · NCT07854210 · Data updated 2026-11-12

This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment70 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedNovember 3, 2025
Main results expectedNovember 2026
Study endsDecember 2026
Registry record updatedOctober 2, 2026
Trial IDNCT07854210 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with COPD hospitalized for mild-to-moderate hypercapnic respiratory failure, able to cooperate with the assigned therapy.

Probably not a fit

Patients with severe acidosis, instability, facial trauma, nasal deformities, urgent need for invasive ventilation, or non-cooperation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two noninvasive respiratory support methods in adults hospitalized for COPD with mild-to-moderate hypercapnic respiratory failure. Patients are randomized or otherwise allocated to receive either high-flow nasal cannula or noninvasive ventilation to monitor gas exchange trends, clinical outcomes, and tolerability. The trial aims to determine which approach provides better physiological improvement and patient experience. It excludes patients with severe acidosis, instability, or conditions that could confound outcomes, ensuring a focus on tolerability and efficacy in this specific COPD subset. Conducted at the Faculty of Medicine, Mansoura University, under lead sponsor Mohammed Shehta, the study evaluates practical applicability of HFNC in this patient population.

Why it matters

Potential benefit: If successful, patients with COPD and hypercapnic respiratory failure could have a more comfortable and potentially effective respiratory support option.

How similar studies have gone: Previous work in noninvasive support for COPD has shown benefits with NIV; this study explores HFNC in a similar clinical scenario and may provide comparative data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* COPD patients hospitalized with mild-to-moderate hypercapnic respiratory failure, defined as arterial pH \[range, e.g., 7.25-7.35\] and PaCO2 \[threshold, e.g., \>45 mmHg and less 60 mmHg\].

Exclusion Criteria:

* patients with altered mental state, confused, severe agitation or not cooperative were excluded. Also, severe acidosis (pH \<7.25), hemodynamic instability, facial trauma or surgery, cases with severe nasal deformity, immediate indication for invasive ventilation, patient refusal, cases with respiratory rate more than 35 breaths per minute. Respiratory exhaustion, excess use of respiratory accessory muscles, Patients with breathing disorders during sleep as well as cases of upper airway obstruction and patients with history of chronic home ventilation prior admission were another items for exclusion

Where it's running

  • Faculty of Medicine, Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.